Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Mallinckrodt
Dow
Colorcon
Express Scripts

Last Updated: November 30, 2021

DrugPatentWatch Database Preview

DR REDDYS LABS SA Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for DR REDDYS LABS SA, and when can generic versions of DR REDDYS LABS SA drugs launch?

DR REDDYS LABS SA has twelve approved drugs.

There are five US patents protecting DR REDDYS LABS SA drugs.

There are thirty-one patent family members on DR REDDYS LABS SA drugs in fifteen countries and ten supplementary protection certificates in seven countries.

Summary for DR REDDYS LABS SA
International Patents:31
US Patents:5
Tradenames:9
Ingredients:9
NDAs:12

Drugs and US Patents for DR REDDYS LABS SA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Sa XEGLYZE abametapir LOTION;TOPICAL 206966-001 Jul 24, 2020 DISCN Yes No 9,357,783 ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Dr Reddys Labs Sa NICOTINE POLACRILEX nicotine polacrilex TROCHE/LOZENGE;ORAL 212796-002 Jan 8, 2020 OTC No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Dr Reddys Labs Sa TOBRAMYCIN tobramycin SOLUTION;INHALATION 207080-001 Jul 9, 2018 AN RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Dr Reddys Labs Sa BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE buprenorphine hydrochloride; naloxone hydrochloride FILM;BUCCAL, SUBLINGUAL 205299-001 Jun 14, 2018 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Dr Reddys Labs Sa FENOFIBRATE (MICRONIZED) fenofibrate CAPSULE;ORAL 090859-002 Mar 1, 2012 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-006 Nov 12, 1999 OTC Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for DR REDDYS LABS SA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-006 Nov 12, 1999 4,597,961 ⤷  Free Forever Trial
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-006 Nov 12, 1999 5,016,652 ⤷  Free Forever Trial
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-004 Nov 12, 1999 4,597,961 ⤷  Free Forever Trial
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-006 Nov 12, 1999 5,834,011 ⤷  Free Forever Trial
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-005 Nov 12, 1999 4,597,961 ⤷  Free Forever Trial
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-005 Nov 12, 1999 5,834,011 ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for DR REDDYS LABS SA Drugs

Country Patent Number Estimated Expiration
Australia 2006207812 ⤷  Free Forever Trial
Brazil PI0606577 ⤷  Free Forever Trial
European Patent Office 3082424 ⤷  Free Forever Trial
New Zealand 544295 ⤷  Free Forever Trial
World Intellectual Property Organization (WIPO) 2005007188 ⤷  Free Forever Trial
Eurasian Patent Organization 201691033 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration

Supplementary Protection Certificates for DR REDDYS LABS SA Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0720599 03C0028 France ⤷  Free Forever Trial PRODUCT NAME: EZETIMIBE; NAT. REGISTRATION NO/DATE: NL28237 20030611; FIRST REGISTRATION: DE - 54486.00.00 A 54489.00.00 20021017
1280520 C300722 Netherlands ⤷  Free Forever Trial PRODUCT NAME: TOBRAMYCINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: C(2011)5394 20110720
1280520 92678 Luxembourg ⤷  Free Forever Trial PRODUCT NAME: TOBRAMYCINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE QUI EN DERIVE. FIRST REGISTRATION: 20110725
1280520 CA 2015 00017 Denmark ⤷  Free Forever Trial PRODUCT NAME: TOBRAMYCIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/10/652/001-003 20110720
1280520 C01280520/01 Switzerland ⤷  Free Forever Trial PRODUCT NAME: TOBRAMYCIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 60565 01.02.2012
1273292 C01273292/01 Switzerland ⤷  Free Forever Trial PRODUCT NAME: TOBRAMYCIN; REGISTRATION NO/DATE: SWISSMEDIC 58751 28.05.2009
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Dow
Mallinckrodt
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.